Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
CD37 VHH recombinant monoclonal antibody
CD38 VHH recombinant monoclonal antibody
CD4 VHH recombinant monoclonal antibody
CD40 VHH recombinant monoclonal antibody
CD41 VHH recombinant monoclonal antibody
CD52 VHH recombinant monoclonal antibody
CD6 VHH recombinant monoclonal antibody
CD61 VHH recombinant monoclonal antibody
CD70 VHH recombinant monoclonal antibody
CD74 VHH recombinant monoclonal antibody
CD79B VHH recombinant monoclonal antibody
CD80 VHH recombinant monoclonal antibody